Jefferies Financial Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-33,400
Closed -$3.37M 1333
2025
Q1
$3.37M Sell
33,400
-68,700
-67% -$6.92M 0.03% 416
2024
Q4
$9.12M Sell
102,100
-129,600
-56% -$11.4M 0.05% 243
2024
Q3
$19.4M Sell
231,700
-3,800
-2% -$300K 0.14% 95
2024
Q2
$18.1M Buy
+235,500
New +$17.2M 0.19% 88
2023
Q1
Sell
-50,000
Closed -$2.31M 1649
2022
Q4
$2.31M Buy
+50,000
New +$2.17M 0.02% 607

Other funds holding BSX

Jefferies Financial Group's BSX Position: Q1 2026 in Review

Jefferies Financial Group reduced its Boston Scientific (BSX) stake by 95% in Q1 2026, selling an estimated $20.4M and leaving 14,014 shares worth $879K. The position accounts for 0.01% of the portfolio, ranked #978.

Jefferies Financial Group first reported a position in BSX in Q2 2018 and has held it in 15 quarters since. The position peaked at $66.3M in Q2 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Jefferies Financial Group held 14,014 shares of Boston Scientific worth $879K as of Q1 2026.
  • Jefferies Financial Group sold 254,806 Boston Scientific shares in Q1 2026, an estimated $20.4M.
  • Boston Scientific made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #978 holding.
  • Jefferies Financial Group first reported a position in Boston Scientific in Q2 2018 and has held it in 15 quarters since.
  • Jefferies Financial Group's Boston Scientific position peaked at $66.3M in Q2 2024.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.